Search Results - "Jarnagin"

The Landmark Series: Hilar Cholangiocarcinoma by Soares, Kevin C., Jarnagin, William R.

“…Hilar cholangiocarcinoma (HC) is a rare and highly aggressive biliary tract neoplasm. As such, the data driving the management of this disease generally are…”
Get full text

LOOKS CAN BE DECEIVING: A CASE OF RAPIDLY GROWING METASTATIC SQUAMOUS CELL CARCINOMA "HIDING" IN THE ANTERIOR MEDIASTINUM by WELSH, IAN, JARNAGIN, LISA

Get full text

The role and structure of the Brazilian imperial nobility in society and politcs by Laura Jarnagin

“…Neste trabalho, apresentado em 1977 na Vanderbilt University (Nashvillc, Tennessee, USA), para obtenção do título de Master of Arts em estudos…”
Get full text

Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver by Costa-Silva, Bruno, Aiello, Nicole M., Ocean, Allyson J., Singh, Swarnima, Zhang, Haiying, Thakur, Basant Kumar, Becker, Annette, Hoshino, Ayuko, Mark, Milica Tešić, Molina, Henrik, Xiang, Jenny, Zhang, Tuo, Theilen, Till-Martin, García-Santos, Guillermo, Williams, Caitlin, Ararso, Yonathan, Huang, Yujie, Rodrigues, Gonçalo, Shen, Tang-Long, Labori, Knut Jørgen, Lothe, Inger Marie Bowitz, Kure, Elin H., Hernandez, Jonathan, Doussot, Alexandre, Ebbesen, Saya H., Grandgenett, Paul M., Hollingsworth, Michael A., Jain, Maneesh, Mallya, Kavita, Batra, Surinder K., Jarnagin, William R., Schwartz, Robert E., Matei, Irina, Peinado, Héctor, Stanger, Ben Z., Bromberg, Jacqueline, Lyden, David

“…Pancreatic ductal adenocarcinomas (PDACs) are highly metastatic with poor prognosis, mainly due to delayed detection. We hypothesized that intercellular…”
Get full text

Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention by Lowery, Maeve A, Ptashkin, Ryan, Jordan, Emmet, Berger, Michael F, Zehir, Ahmet, Capanu, Marinela, Kemeny, Nancy E, O'Reilly, Eileen M, El-Dika, Imane, Jarnagin, William R, Harding, James J, D'Angelica, Michael I, Cercek, Andrea, Hechtman, Jaclyn F, Solit, David B, Schultz, Nikolaus, Hyman, David M, Klimstra, David S, Saltz, Leonard B, Abou-Alfa, Ghassan K

“…Various genetic driver aberrations have been identified among distinct anatomic and clinical subtypes of intrahepatic and extrahepatic cholangiocarcinoma, and…”
Get full text

Distal Pancreatectomy: A Single Institution's Experience in Open, Laparoscopic, and Robotic Approaches by Lee, Ser Yee, MBBS, MSc, MMed, FRCS(Ed), Allen, Peter J., MD, FACS, Sadot, Eran, MD, D’Angelica, Michael I., MD, FACS, DeMatteo, Ronald P., MD, FACS, Fong, Yuman, MD, FACS, Jarnagin, William R., MD, FACS, Kingham, T. Peter, MD, FACS

“…Background The indications for minimally invasive (MIS) pancreatectomy have slowly increased as experience, techniques, and technology have improved and…”
Get full text

Gallbladder carcinoma by Miller, G, Jarnagin, W.R

“…Abstract Although it is the most common cancer of the biliary tree, gallbladder carcinoma remains an uncommon disease. As a result, many clinicians rarely…”
Get full text

Selecting Patients for Resection of Multifocal HCC Beyond Milan Criteria: Does the Tumor Burden Score Help? by Jarnagin, William R.

Get full text

Postoperative Mortality after Liver Resection for Perihilar Cholangiocarcinoma: Development of a Risk Score and Importance of Biliary Drainage of the Future Liver Remnant by Wiggers, Jimme K., MD, PhD, Koerkamp, Bas Groot, MD, PhD, Cieslak, Kasia P., MD, Doussot, Alexandre, MD, van Klaveren, David, PhD, Allen, Peter J., MD, FACS, Besselink, Marc G., MD, PhD, Busch, Olivier R., MD, PhD, D’Angelica, Michael I., MD, FACS, DeMatteo, Ronald P., MD, FACS, Gouma, Dirk J., MD, PhD, Kingham, T Peter, MD, FACS, van Gulik, Thomas M., MD, PhD, Jarnagin, William R., MD, FACS

“…Abstract Background Liver surgery for perihilar cholangiocarcinoma (PHC) is associated with postoperative mortality ranging from 5% to 18%. The aim of this…”
Get full text

GNAS and KRAS Mutations Define Separate Progression Pathways in Intraductal Papillary Mucinous Neoplasm-Associated Carcinoma by Tan, Marcus C., MBBS (Hons), Basturk, Olca, MD, Brannon, A. Rose, PhD, Bhanot, Umesh, MD, PhD, Scott, Sasinya N., MS, Bouvier, Nancy, BS, LaFemina, Jennifer, MD, FACS, Jarnagin, William R., MD, FACS, Berger, Michael F., PhD, Klimstra, David, MD, Allen, Peter J., MD, FACS

“…Background Intraductal papillary mucinous neoplasms (IPMN) are being increasingly recognized as important precursors to pancreatic adenocarcinoma. Elucidation…”
Get full text

DIFFUSE RECURRENT RESPIRATORY PAPILLOMATOSIS AFTER IMMUNOSUPRESSIVE THERAPY by JARNAGIN, LISA, ALALAWI, RAED

Get full text

ENDOBRONCHIAL VALVE EXCHANGE FOLLOWING BRONCHOSCOPIC LUNG VOLUME REDUCTION FOR MANAGEMENT OF COUGH by JARNAGIN, LISA, ALALAWI, RAED

Get full text

Recurrence Patterns and Disease-Free Survival after Resection of Intrahepatic Cholangiocarcinoma: Preoperative and Postoperative Prognostic Models by Doussot, Alexandre, MD, Gonen, Mithat, PhD, Wiggers, Jimme K., MD, PhD, Groot-Koerkamp, Bas, MD, PhD, DeMatteo, Ronald P., MD, FACS, Fuks, David, MD, PhD, Allen, Peter J., MD, FACS, Farges, Olivier, MD, PhD, Kingham, T Peter, MD, FACS, Regimbeau, Jean Marc, MD, PhD, D'Angelica, Michael I., MD, FACS, Azoulay, Daniel, MD, PhD, Jarnagin, William R., MD, FACS

“…Background Liver resection is the most effective treatment for intrahepatic cholangiocarcinoma. Recurrent disease is frequent; however, recurrence patterns are…”
Get full text

Tau Positron-Emission Tomography in Former National Football League Players by Stern, Robert A, Adler, Charles H, Chen, Kewei, Navitsky, Michael, Luo, Ji, Dodick, David W, Alosco, Michael L, Tripodis, Yorghos, Goradia, Dhruman D, Martin, Brett, Mastroeni, Diego, Fritts, Nathan G, Jarnagin, Johnny, Devous, Michael D, Mintun, Mark A, Pontecorvo, Michael J, Shenton, Martha E, Reiman, Eric M

“…Twenty-six former NFL players with cognitive and behavioral symptoms were compared with controls by means of tau PET. Tau deposition was found in the temporal,…”
Get full text

Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival by Jarnagin, W.R., Schwartz, L.H., Gultekin, D.H., Gönen, M., Haviland, D., Shia, J., D'Angelica, M., Fong, Y., DeMatteo, R., Tse, A., Blumgart, L.H., Kemeny, N.

“…This study reports the results of hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone (dex) in patients with unresectable intrahepatic…”
Get full text

Hepatic Parenchymal Preservation Surgery: Decreasing Morbidity and Mortality Rates in 4,152 Resections for Malignancy by Kingham, T. Peter, MD, FACS, Correa-Gallego, Camilo, MD, D’Angelica, Michael I., MD, FACS, Gönen, Mithat, PhD, DeMatteo, Ronald P., MD, FACS, Fong, Yuman, MD, FACS, Allen, Peter J., MD, FACS, Blumgart, Leslie H., MD, FACS, Jarnagin, William R., MD, FACS

“…Background Liver resection is used to treat primary and secondary malignancies. Historically, these procedures were associated with significant complications,…”
Get full text

Recurrence Rate and Pattern of Perihilar Cholangiocarcinoma after Curative Intent Resection by Groot Koerkamp, Bas, MD, PhD, Wiggers, Jimme K., MD, Allen, Peter J., MD, FACS, Besselink, Marc G., MD, PhD, Blumgart, Leslie H., MD, FACS, Busch, Olivier R.C., MD, PhD, Coelen, Robert J., MD, D'Angelica, Michael I., MD, FACS, DeMatteo, Ronald P., MD, FACS, Gouma, Dirk J., MD, PhD, Kingham, T. Peter, MD, FACS, Jarnagin, William R., MD, FACS, van Gulik, Thomas M., MD, PhD

“…Background The aim of this study was to investigate the rate and pattern of recurrence after curative intent resection of perihilar cholangiocarcinoma (PHC)…”
Get full text

Survival after Hepatic Resection for Metastatic Colorectal Cancer: Trends in Outcomes for 1,600 Patients during Two Decades at a Single Institution by House, Michael G., MD, Ito, Hiromichi, MD, Gönen, Mithat, PhD, Fong, Yuman, MD, FACS, Allen, Peter J., MD, FACS, DeMatteo, Ronald P., MD, FACS, Brennan, Murray F., MD, FACS, Blumgart, Leslie H., MD, FACS, Jarnagin, William R., MD, FACS, D'Angelica, Michael I., MD, FACS

“…Background This study analyzes factors associated with differences in long-term outcomes after hepatic resection for metastatic colorectal cancer over time…”
Get full text

Actual 10-year survival after hepatic resection of colorectal liver metastases: what factors preclude cure? by Creasy, John M., Sadot, Eran, Koerkamp, Bas Groot, Chou, Joanne F., Gonen, Mithat, Kemeny, Nancy E., Balachandran, Vinod P., Kingham, T. Peter, DeMatteo, Ronald P., Allen, Peter J., Blumgart, Leslie H., Jarnagin, William R., D'Angelica, Michael I.

“…Hepatic resection of colorectal liver metastases is associated with long-term survival. This study analyzes actual 10-year survivors after resection of…”
Get full text

Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set - E-Book by Jarnagin, William R

“…Balancing basic science with information on everyday clinical practice, Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 7th Edition, provides you…”
Get full text